Advertisement

Mutation in Adenosine-Controlling Gene Associated with Early Stroke, Inflammation — Physician’s First Watch

Medical News |
February 20, 2014

Mutation in Adenosine-Controlling Gene Associated with Early Stroke, Inflammation

By Joe Elia

A mutation in CECR1, which normally encodes an enzyme involved in regulating inflammation, has been associated with polyarteritis nodosa, stroke, and other vascular diseases. The findings appear in two studies in the New England Journal of Medicine.

Zhou and colleagues report that CECR1 mutations were associated with marked reductions in adenosine deaminase 2 activity. Five of their nine patients suffered strokes before age 5, and all had recurrent fevers.

In zebrafish experiments, loss of a similar gene caused intracranial bleeding, and brain biopsies from patients showed endothelial damage.

Navon Elkan and colleagues, some of whose patients overlap with Zhou's, describe similar findings in a larger group, including cases of familial pediatric polyarteritis nodosa. They speculate that elevated adenosine levels "may promote tissue injury and fibrosis by prolonging inflammation."

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement